title: Squeezing the middleman: ending underhanded dealing in the pharmacy benefit management industry through regulation.
abstract: Pharmacy benefit management (PBM) companies are the middlemen of the pharmaceutical industry, designing plans for sponsors and insurers and pushing the products of manufacturers. Their unique position can often create conflicts of interest, which has been the basis of much litigation. This article reviews the structure of the PBM industry and analyzes concerns arising from its handling of prescription drug pricing, manufacturer rebates and discounts, and mail order pharmacies. After surveying several legislative proposals, it concludes with a comprehensive outline for legislation to eliminate underhanded dealing in the industry and lower the cost of prescription drugs.
authors.forename: Mark
authors.initials: M
authors.lastname: Meador
mesh_terms: D016363:Antitrust Laws; D005607:Fraud / Q000331:legislation & jurisprudence / Q000517:prevention & control; D033161:Government Regulation; D007356:Insurance, Pharmaceutical Services / Q000191:economics* / Q000331:legislation & jurisprudence*; D014481:United States